Frontier Wealth Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,809
| Closed | -$583K | – | 419 |
|
|
2016
Q3 | $583K | Buy |
3,809
+1,556
| +69% | +$238K | 0.09% | 188 |
|
|
2016
Q2 | $259K | Sell |
2,253
-74
| -3% | -$8.51K | 0.04% | 293 |
|
|
2016
Q1 | $264K | Sell |
2,327
-187
| -7% | -$21.2K | 0.02% | 270 |
|
|
2015
Q4 | $474K | Sell |
2,514
-124
| -5% | -$23.4K | 0.08% | 204 |
|
|
2015
Q3 | $449K | Buy |
2,638
+1,005
| +62% | +$171K | 0.07% | 217 |
|
|
2015
Q2 | $1.03M | Buy |
+1,633
| New | +$1.03M | 0.16% | 127 |
|